ALLURION TECHNOLOGIES, INC.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
UNAUDITED CONDENSED CONSOLI DATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating Activities: | ||
| Net loss | $(6,095) | $(1,501) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Non-cash lease expense | 119 | 212 |
| Depreciation and amortization | 171 | 203 |
| Stock-based compensation | 638 | 897 |
| Provision for uncollectible accounts | — | 72 |
| Unrealized exchange (gain) loss | 90 | (335) |
| Provision for inventory | 433 | 25 |
| Change in fair value of warrant liabilities | (4,324) | (5,669) |
| Warrant inducement expense | 4,145 | — |
| Change in fair value of debt | 750 | (3,330) |
| Change in fair value of Revenue Interest Financing | 1,820 | 3,820 |
| Change in fair value of earn-out liabilities | — | (910) |
| Change in fair value of Share Obligation | (120) | 700 |
| Issuance costs associated with warrants recorded at fair value | 222 | 1,137 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 365 | (883) |
| Inventory | 176 | 22 |
| Prepaid expenses, other current and long-term assets | 172 | 147 |
| Lease liabilities | (73) | (199) |
| Accounts payable | (347) | (2,409) |
| Accrued expenses and other current liabilities | (1,363) | (1,468) |
| Net cash used in operating activities | $(3,221) | $(9,469) |
| Investing Activities: | ||
| Purchases of property and equipment | — | — |
| Net cash used in investing activities | $— | $— |
| Financing Activities: | ||
| Proceeds from equity offerings, net of issuance costs | — | 14,499 |
| Proceeds from warrant inducement, net of issuance costs | 2,866 | — |
| Net cash provided by financing activities | $2,866 | $14,499 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | (355) | 5,030 |
| Cash and cash equivalents and restricted cash at beginning of period | 5,742 | 15,718 |
| Cash and cash equivalents and restricted cash at end of period | $5,387 | $20,748 |
| Supplemental cash flow information on non-cash investing and financing activities | ||
| Deferred financing costs in accounts payable and accrued expenses | $155 | $921 |
| Change in fair value of RTW Convertible Notes through OCI | 270 | 1,420 |
| Change in fair value of Revenue Interest Financing through OCI | 720 | 3,020 |
A reconciliation of the amounts of cash and cash equivalents and restricted cash in the condensed consolidated balance sheets to the amount in the condensed consolidated statements of cash flows is as follows (in thousands):
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Cash and cash equivalents | $5,056 | $5,412 |
| Restricted cash included in other long-term assets | 331 | 330 |
| Cash and cash equivalents and restricted cash shown in the statement of cash flows | $5,387 | $5,742 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.